Industry Roundup: GMP Warning, MedGen/Alternaturals Merger
This article was originally published in The Tan Sheet
Executive Summary
FDA finds chaos at Chaotic Labz; investor facilitates MedGen, Alternaturals combination; more news in brief.
You may also be interested in...
FDA Holds Marketers Responsible For Manufacturers’ GMP Violations
FDA has begun holding own-label dietary supplement marketers responsible for their contract manufacturers’ violations of good manufacturing practices.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.